Abstract
Abstract only
- Title
- A phase 3 randomized double-blind trial of maintenance with niraparib versus placebo in patients with platinum-sensitive ovarian cancer (ENGOT-OV16/NOVA trial)
- Creators
- Ursula Matulonis - Dana-Farber Cancer InstituteSven Mahner - University Medical Center Hamburg-EppendorfRobert Michael Wenham - Moffitt Cancer CenterJonathan A. Ledermann - University College LondonBradley J. Monk - Creighton UniversityJose Maria Del Campo - Vall d'Hebron Institute of Oncology, Barcelona, SpainJonathan S. Berek - Cancer Prevention Institute of CaliforniaIgnace Vergote - KU LeuvenMichel Fabbro - ICM, Montpellier, FranceDionyssios Katsaros - Ospedale Sant'AnnaChristian Marth - Innsbruck Medical UniversityDomenica Lorusso - Ministry of Infrastructures and TransportJorn Herrstedt - Odense University HospitalShefali Agarwal - TesaroRobert E. Martell - TesaroMansoor Raza Mirza - Danish Gynecologic Cancer Group, Copenhagen, Denmark
- Publication Details
- Journal of clinical oncology, Vol.32(15_suppl), pp.TPS5625-TPS5625
- Identifiers
- 991005968876002656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article